The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms
Clinical trial NCT04854759 · UNKNOWN
Trial details
- NCT number
- NCT04854759
- Sponsor
- Independent Public Clinical Hospital No. 4 in Lublin
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-15
- Primary completion
- 2022-03-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.